Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan
· Delayed Price · Currency is TWD 46.20
-0.10 (-0.22%)
Apr 29, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4.01 billion as of April 29, 2026. Its market cap has decreased by -7.97% in one year.
Market Cap
4.01B
Enterprise Value
6.25B
Revenue
4.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.20
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.01B, an increase of 471.87%. That is a compound annual growth rate of 8.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merdury Biopharmaceutical | 3.50B |
| Easywell Biomedicals | 5.02B |
| Allied Biotech | 3.08B |
| Maywufa Company | 2.90B |
| LIWANLI Innovation | 5.73B |
| SCI Pharmtech | 5.77B |
| Orient Pharma | 5.81B |
| Formosa Laboratories | 6.16B |